Silvia J Serrano-Gomez1, Maria Carolina Sanabria-Salas2, Laura Fejerman3. 1. Grupo de investigación en biología del cáncer, Instituto Nacional de Cancerología, Bogotá, Colombia. 2. Subdirección de Investigaciones - Instituto Nacional de Cancerología, Bogotá, Colombia. 3. Department of Medicine, Division of General Internal Medicine, University of California San Francisco, CA.
Abstract
PURPOSE OF THE REVIEW: Breast cancer incidence and mortality rates are lower in some Hispanic/Latino subpopulations compared to Non-Hispanic White women. However, studies suggest that the risk of breast cancer-specific mortality is higher in US Hispanics/Latinas. In this review we summarized current knowledge on factors associated with breast cancer incidence and risk of mortality in women of Hispanic/Latino origin. RECENT FINDINGS: Associative studies have proposed a multiplicity of factors likely contributing to differences in breast cancer incidence and survival between population groups, including socioeconomic/sociodemographic factors, lifestyle choices as well as access to and quality of care. Reports of association between global genetic ancestry overall as well as subtype-specific breast cancer risk among Hispanic/Latinas suggest that incidence and subtype distribution could result from differential exposure to environmental and lifestyle related factors correlated with genetic ancestry as well as germline genetic variation. SUMMARY: Hispanic/Latino in the United States have been largely underrepresented in cancer research. It is important to implement inclusive programs that facilitate the access of this population to health services and that also include education programs for the community on the importance of screening. In addition, it is important to continue promoting the inclusion of Hispanics/Latinos in genomic studies that allow understanding the biological behavior of this disease in the context of all human genetic diversity.
PURPOSE OF THE REVIEW: Breast cancer incidence and mortality rates are lower in some Hispanic/Latino subpopulations compared to Non-Hispanic White women. However, studies suggest that the risk of breast cancer-specific mortality is higher in US Hispanics/Latinas. In this review we summarized current knowledge on factors associated with breast cancer incidence and risk of mortality in women of Hispanic/Latino origin. RECENT FINDINGS: Associative studies have proposed a multiplicity of factors likely contributing to differences in breast cancer incidence and survival between population groups, including socioeconomic/sociodemographic factors, lifestyle choices as well as access to and quality of care. Reports of association between global genetic ancestry overall as well as subtype-specific breast cancer risk among Hispanic/Latinas suggest that incidence and subtype distribution could result from differential exposure to environmental and lifestyle related factors correlated with genetic ancestry as well as germline genetic variation. SUMMARY: Hispanic/Latino in the United States have been largely underrepresented in cancer research. It is important to implement inclusive programs that facilitate the access of this population to health services and that also include education programs for the community on the importance of screening. In addition, it is important to continue promoting the inclusion of Hispanics/Latinos in genomic studies that allow understanding the biological behavior of this disease in the context of all human genetic diversity.
Entities:
Keywords:
Breast Neoplasms; Hispanic Americans; Risk factors; diagnosis; genetics
Authors: Xiao-Cheng Wu; Mary Jo Lund; Gretchen G Kimmick; Lisa C Richardson; Susan A Sabatino; Vivien W Chen; Steven T Fleming; Cyllene R Morris; Bin Huang; Amy Trentham-Dietz; Joseph Lipscomb Journal: J Clin Oncol Date: 2011-12-05 Impact factor: 44.544
Authors: Christopher R Friese; T May Pini; Yun Li; Paul H Abrahamse; John J Graff; Ann S Hamilton; Reshma Jagsi; Nancy K Janz; Sarah T Hawley; Steven J Katz; Jennifer J Griggs Journal: Breast Cancer Res Treat Date: 2013-03-31 Impact factor: 4.872
Authors: Laura Fejerman; Gary K Chen; Celeste Eng; Scott Huntsman; Donglei Hu; Amy Williams; Bogdan Pasaniuc; Esther M John; Marc Via; Christopher Gignoux; Sue Ingles; Kristine R Monroe; Laurence N Kolonel; Gabriela Torres-Mejía; Eliseo J Pérez-Stable; Esteban González Burchard; Brian E Henderson; Christopher A Haiman; Elad Ziv Journal: Hum Mol Genet Date: 2012-01-06 Impact factor: 6.150
Authors: Laura Fejerman; Mariana C Stern; Elad Ziv; Esther M John; Gabriela Torres-Mejia; Lisa M Hines; Roger Wolff; Wei Wang; Kathy B Baumgartner; Anna R Giuliano; Martha L Slattery Journal: Carcinogenesis Date: 2013-04-04 Impact factor: 4.944
Authors: Amelie Ramirez; Eliseo Perez-Stable; Frank Penedo; Gregory Talavera; J Emilio Carrillo; María Fernández; Alan Holden; Edgar Munoz; Sandra San Miguel; Kipling Gallion Journal: Cancer Date: 2013-11-12 Impact factor: 6.860
Authors: Laura Fejerman; Nasim Ahmadiyeh; Donglei Hu; Scott Huntsman; Kenneth B Beckman; Jennifer L Caswell; Karen Tsung; Esther M John; Gabriela Torres-Mejia; Luis Carvajal-Carmona; María Magdalena Echeverry; Anna Marie D Tuazon; Carolina Ramirez; Christopher R Gignoux; Celeste Eng; Esteban Gonzalez-Burchard; Brian Henderson; Loic Le Marchand; Charles Kooperberg; Lifang Hou; Ilir Agalliu; Peter Kraft; Sara Lindström; Eliseo J Perez-Stable; Christopher A Haiman; Elad Ziv Journal: Nat Commun Date: 2014-10-20 Impact factor: 14.919
Authors: Marcia Cruz-Correa; Julyann Pérez-Mayoral; Julie Dutil; Miguel Echenique; Rafael Mosquera; Keila Rivera-Román; Sharee Umpierre; Segundo Rodriguez-Quilichini; Maria Gonzalez-Pons; Myrta I Olivera; Sherly Pardo Journal: Hered Cancer Clin Pract Date: 2017-01-21 Impact factor: 2.857
Authors: Claire C Conley; Jessica N Rivera Rivera; Eida M Castro-Figueroa; Laura Moreno; Julie Dutil; Jennifer D García; Charité Ricker; Gwendolyn P Quinn; Hatem Soliman; Susan T Vadaparampil Journal: Transl Behav Med Date: 2022-10-07 Impact factor: 3.626
Authors: Paola Gonzalo-Encabo; Rebekah L Wilson; Dong-Woo Kang; Mary K Norris; Hajime Uno; Cami N Christopher; Christina Chow; Nathalie Sami; Frank S Fox; Jennifer A Ligibel; Christina M Dieli-Conwright Journal: Front Oncol Date: 2022-05-10 Impact factor: 5.738